Renal dysfunction accounts for the dose limiting toxicity of DT390anti-CD3sFv, a potential new recombinant anti-GVHD immunotoxin. [electronic resource]
- Protein engineering Sep 1997
- 1071-6 p. digital
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.